DK1305082T3 - Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte - Google Patents

Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte

Info

Publication number
DK1305082T3
DK1305082T3 DK01952773T DK01952773T DK1305082T3 DK 1305082 T3 DK1305082 T3 DK 1305082T3 DK 01952773 T DK01952773 T DK 01952773T DK 01952773 T DK01952773 T DK 01952773T DK 1305082 T3 DK1305082 T3 DK 1305082T3
Authority
DK
Denmark
Prior art keywords
pain
cluster
migraine headache
prevention
phenyl
Prior art date
Application number
DK01952773T
Other languages
English (en)
Inventor
Ellen E Codd
Richard P Shank
Katherine E Rogers
Carlos R Plata-Salaman
Boyu Zhao
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1305082(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1305082T3 publication Critical patent/DK1305082T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01952773T 2000-07-21 2001-07-16 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte DK1305082T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21965700P 2000-07-21 2000-07-21

Publications (1)

Publication Number Publication Date
DK1305082T3 true DK1305082T3 (da) 2004-09-13

Family

ID=22820176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01952773T DK1305082T3 (da) 2000-07-21 2001-07-16 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte

Country Status (28)

Country Link
US (4) US20020107283A1 (da)
EP (1) EP1305082B1 (da)
JP (1) JP5271473B2 (da)
KR (1) KR100792814B1 (da)
CN (1) CN1250213C (da)
AT (1) ATE267629T1 (da)
AU (2) AU7349301A (da)
BG (1) BG107529A (da)
BR (1) BR0112713A (da)
CA (1) CA2416819C (da)
CZ (1) CZ2003445A3 (da)
DE (1) DE60103546T2 (da)
DK (1) DK1305082T3 (da)
EA (1) EA005648B1 (da)
ES (1) ES2221651T3 (da)
HU (1) HUP0302940A3 (da)
IL (2) IL154052A0 (da)
MX (1) MXPA03000619A (da)
MY (1) MY127317A (da)
NO (1) NO330055B1 (da)
NZ (1) NZ523851A (da)
PL (1) PL365701A1 (da)
PT (1) PT1305082E (da)
SK (1) SK1962003A3 (da)
TR (1) TR200401511T4 (da)
UA (1) UA74195C2 (da)
WO (1) WO2002007822A2 (da)
ZA (1) ZA200301403B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2356617T3 (es) * 2001-02-27 2011-04-11 Ortho-Mcneil Pharmaceutical, Inc. Compuestos de carbamato para su uso en el tratamiento del dolor.
JP4362368B2 (ja) * 2001-07-16 2009-11-11 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物
ES2327721T3 (es) 2001-07-16 2009-11-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Compuestos de carbamato para uso en la prevencion o tratamiento del dolor neuropatico.
US20040087642A1 (en) * 2002-10-24 2004-05-06 Zeldis Jerome B. Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
AU2003293500A1 (en) * 2002-12-12 2004-07-09 Agennix Incorporated Lactoferrin in the reduction of pain
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
EA200701536A1 (ru) * 2005-01-20 2008-02-28 Янссен Фармацевтика, Н.В. Способы контроля интервала qt
EP1998802A2 (en) 2006-03-30 2008-12-10 GlaxoSmithKline Biologicals S.A. Immunogenic composition
EP2076135A2 (en) * 2006-10-10 2009-07-08 Janssen Pharmaceutica, N.V. Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) * 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU191549B (en) * 1984-04-11 1987-03-30 Richter Gedeon Vegyeszet Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) * 1995-09-05 1995-11-08 Wellcome Found Pharmacologically active compound
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU8025198A (en) * 1997-06-05 1998-12-21 Sanofi-Synthelabo 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
RS51056B (sr) * 2001-02-27 2010-10-31 Ortho-Mcneil Pharmaceutical Inc. Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju psihotičkih poremećaja
IL157590A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating bipolar disorder
NZ551954A (en) * 2001-02-27 2008-07-31 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating movement disorders

Also Published As

Publication number Publication date
US20090281179A1 (en) 2009-11-12
JP5271473B2 (ja) 2013-08-21
TR200401511T4 (tr) 2004-08-23
WO2002007822A2 (en) 2002-01-31
US20020107283A1 (en) 2002-08-08
HUP0302940A3 (en) 2012-02-28
CZ2003445A3 (cs) 2004-08-18
BG107529A (bg) 2003-09-30
AU2001273493B2 (en) 2005-08-11
MXPA03000619A (es) 2004-07-30
EP1305082A2 (en) 2003-05-02
NO20030299L (no) 2003-03-12
JP2004504362A (ja) 2004-02-12
IL154052A0 (en) 2003-07-31
US20040266866A1 (en) 2004-12-30
EP1305082B1 (en) 2004-05-26
NO330055B1 (no) 2011-02-14
DE60103546D1 (de) 2004-07-01
US20060183795A1 (en) 2006-08-17
ATE267629T1 (de) 2004-06-15
NZ523851A (en) 2004-09-24
CA2416819C (en) 2011-03-22
NO20030299D0 (no) 2003-01-20
BR0112713A (pt) 2003-07-22
EA200300042A1 (ru) 2003-06-26
CN1458853A (zh) 2003-11-26
WO2002007822A3 (en) 2002-05-30
PT1305082E (pt) 2004-09-30
UA74195C2 (uk) 2005-11-15
IL154052A (en) 2008-07-08
CN1250213C (zh) 2006-04-12
EA005648B1 (ru) 2005-04-28
KR20030022300A (ko) 2003-03-15
KR100792814B1 (ko) 2008-01-14
DE60103546T2 (de) 2005-06-09
ZA200301403B (en) 2004-06-15
SK1962003A3 (en) 2004-08-03
PL365701A1 (en) 2005-01-10
HUP0302940A2 (hu) 2003-12-29
MY127317A (en) 2006-11-30
AU7349301A (en) 2002-02-05
ES2221651T3 (es) 2005-01-01
CA2416819A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
DK1305082T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1408954T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte
HK1063288A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain